Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori antibiotic resistance: genetic basis and clinical outcomes
PACTR202208494077478Phase 3Completed
- Sponsor
- Benha University
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin and clarithromycin in Helicobacter pylori infection (2 arms), sponsored by Benha University. Started Nov 2020; status: completed.
02
Drugs
levofloxacinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202208494077478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202208494077478.